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Purpose: To report an undiagnosed case of systemic sarcoidosis manifesting with 
bilateral acute posterior multifocal placoid pigment epitheliopathy (APMPPE).
Case Report: A 26-year-old Caucasian man was referred for management of unilateral 
visual loss together with a paracentral scotoma developing 2 weeks after a flu-like 
syndrome. Clinical signs and ancillary diagnostic investigations suggested APMPPE. 
Laboratory tests demonstrated elevated serum angiotensin converting enzyme and 
lysozyme levels. Chest CT-scan disclosed moderate hilar lymph node calcifications 
but QuantiFERON-TB gold test was negative and bronchoalveolar lavage and 
biopsies were unremarkable. Accessory salivary gland biopsy disclosed epithelioid 
and gigantocellular granuloma formation without caseum, confirming a diagnosis of 
sarcoidosis. The fellow eye was involved a few days later and the patient complained 
of dyspnea. Echocardiography disclosed severe granulomatous myocardial infiltration 
and high dose corticosteroids and intravenous cyclophosphamide were initiated. 
Systemic treatment controlled both cardiac and ocular lesions, and was tapered 
accordingly.
Conclusion: The constellation of “white dot syndromes” and systemic symptoms 
necessitates a general work-up to exclude granulomatous disorders such as sarcoidosis 
or tuberculosis. Delayed diagnosis of cardiac sarcoidosis may have life-threatening 
consequences and the ophthalmologist may be the first physician to diagnose the 
condition.
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INTRODUCTION
In 1968, Gass described 3 young patients 
presenting with rapid central visual loss 
secondary to multifocal, yellow-white, placoid 
lesions at the level of the retinal pigment 
epithelium (RPE) and choroid. The disorder 
was transient and presumed to involve the 
RPE. It was named under the descriptive term 
of acute posterior multifocal placoid pigment 
epitheliopathy (APMPPE).1
The pathophysiology and the level of 
posterior segment involvement in APMPPE 
were controversial before the availability of Sarcoidosis Manifesting as APMPPE; Darugar et al
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indocyanine green angiography (ICGA) and 
optical coherence tomography (OCT). APMPPE 
is an uncommon condition presenting in 
otherwise healthy young adults. It may rarely be 
associated with a wide range of disorders such 
as tuberculosis,2 Wegener’s granulomatosis,3 
cerebral vasculitis,4 vaccination for hepatitis 
B virus,5 adenovirus type 5 infection,6 Lyme 
disease7,8 and varicella vaccination9.
Herein, we present a young patient 
presenting with APMPPE as the initial 
manifestation of severe systemic sarcoidosis.
CASE REPORT
A 26-year-old man was referred to our clinic 
for blurred vision and black spots in his left 
eye starting 3 days prior to referral. He was a 
healthy man with a history of allergic rhinitis 
and contact with cats. He reported a flu-like 
syndrome 2 weeks before the onset of visual 
symptoms which had regressed spontaneously. 
There were no signs of CNS involvement.
At presentation, visual acuity was 20/20, 
the anterior segment was unremarkable, 
intraocular pressure (IOP) was normal, and 
the vitreous cavity was clear in both eyes. 
Multiple deep gray-white placoid lesions in 
the posterior pole of both eyes were observed 
on fundus examination (Fig. 1), some of which 
were partially pigmented.
Goldmann visual field revealed multiple 
small paracentral scotoma in both eyes sparing 
the fovea. Fluorescein angiography disclosed 
early hyperfluorescent lesions at the posterior 
pole with late staining, without macular edema 
or papillitis (Figures 2 and 3). This appearance 
was compatible with old lesions together with 
mild active inflammation. ICGA demonstrated 
multiple hypofluorescent lesions during the 
whole sequence disclosing more lesions than 
apparent on fundus examination and fluorescein 
angiography (Fig. 4). OCT showed hyper-
reflectivity and alterations at the level of the 
photoreceptors and RPE (Fig. 5). The multifocal 
electroretinogram was normal.
Ancillary tests revealed elevated serum 
levels of angiotensin converting enzyme (1.5 
times normal) and lysozyme (1.8 times normal). 
Complete blood cell count, C-reactive protein, 
Figure 1.  Fundus photograph at presentation reveals 
multifocal white-yellow lesions predominantly in the 
left eye.
Figure 2. (a) Early and (b) intermediate fluorescein 
angiography frames show hyperfluorescence with 
moderate staining in the right eye.
Figure 3. (a) Early and (b) intermediate fluorescein 
angiography frames show hyperfluorescence with 
moderate staining in the left eye.
Figure 4. (a) Early and (b) late ICGA frames reveal more 
extensive areas of hypofluorescence in the left eye as 
compared to lesions observed on the fundus photograph.Sarcoidosis Manifesting as APMPPE; Darugar et al
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liver and renal function tests were normal. 
Tuberculin skin test was positive with an 
induration of 10 mm, however the patient 
had previous BCG (bacille Calmette-Guerin) 
vaccination and the QuantiFERON-TB Gold test 
was negative. Furthermore, Syphilis, Lyme and 
HIV serology, antinuclear antibody (ANA) and 
anti-neutrophil cytoplasmic antibody (ANCA) 
were all negative. Chest CT scan showed 
moderate hilar lymph node calcifications 
without adenomegaly and abdominal CT scan 
was normal.
Bronchoalveolar lavage disclosed an 
inflammatory mucosa and macrophage 
alveolitis, compatible with smoking. Bronchial 
biopsies were normal. Accessory salivary 
gland biopsy disclosed an epithelioid and 
gigantocellular granulomatous reaction without 
caseum confirming the diagnosis of sarcoidosis.
Twelve days after referral, the patient 
presented with the same symptoms in the 
fellow eye. Visual acuity was 20/20 in both 
eyes, and the anterior segments and IOP were 
also normal. Mild bilateral vitritis was noted 
and fundus examination revealed stable lesions 
which were more pigmented on the left side. 
Visual field had improved in the left eye and 
was normal in the right eye.
The patient was monitored every 2 
weeks. Symptoms were decreasing and 
visual field defects were improving but the 
patient still complained of visual discomfort. 
Echocardiography disclosed severe cardiac 
involvement explaining his dyspnea. Based on 
cardiac alterations and after multidisplinary 
consultation, cyclophosphamide was initiated 
together with high dose systemic corticosteroids 
followed by slow tapering after stabilization. 
Visual discomfort decreased and visual acuity 
remained stable within two years of follow- up, 
with no further ocular relapses.
DISCUSSION
After the initial report by Gass in the late 
1960s, Ryan and Maumenee described nine 
other patients with APMPPE in 1972 and made 
similar observations favoring Gass’s hypothesis 
that the RPE is primarily involved rather 
than the choroid.10 However, Deutman et al 
later proposed that acute inflammation at the 
level of the choriocapillaris is the underlying 
pathophysiology in APMPPE and that RPE 
changes are a subsequent manifestation.11 
Choroidal hypoperfusion (established by ICGA) 
could be a likely mechanism of injury leading 
to RPE scarring without permanent retinal 
photoreceptor damage.12 This can explain 
why the visual prognosis is usually, but not 
invariably, good.
Spectral domain OCT in the acute phase 
of APMMPE shows disruption of the hyper- 
reflective bands representing the inner-outer 
segment junction and the Verhoeff membrane. 
However, these lesions are also seen after 
healing in areas that initially appeared normal 
on OCT. It is hypothesized that in addition 
to the inflammatory component, secondary 
degenerative changes of the photoreceptors 
and RPE may play a role in tissue destruction, 
resulting in the commonly recognized 
pigmentary changes observed in resolved 
APMPPE.13
Sarcoidosis affects the eye and optic nerve 
in different manners and approximately 20% 
of patients have already developed ocular 
lesions at the time of initial examination. In 
biopsy-proven disease the incidence seems 
even higher.14 Anterior segment disease occurs 
more commonly, usually manifesting as chronic 
granulomatous uveitis. Posterior segment 
involvement occurs less frequently and is rarely 
isolated. Chorioretinitis, periphlebitis, and 
chorioretinal nodules are the most frequently 
described lesions.15-16 RPE alterations usually 
occur peripherally and are not associated 
with visual disturbances.16 Vitreous opacities 
Figure 5. Spectral domain OCT shows hyper-reflectivity 
at the level of the RPE.Sarcoidosis Manifesting as APMPPE; Darugar et al
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and choroidal granulomas may also occur. 
Conjunctival and lacrimal gland involvement, 
papilledema, and direct granulomatous 
involvement of the optic nerve17 and chiasma18 
have also been reported.
Dick et al were the first to report the 
association between APMPPE and sarcoidosis.19 
They described a 24-year-old male patient 
presenting with a flu-like prodrome followed 
by development of multiple scotomata 10 days 
later. After another 6 weeks, he presented with 
bilateral anterior uveitis and small recurrent 
oral ulcers. The patient demonstrated CNS 
involvement with myeloradiculopathy and 
polyadenopathy with epithelioid granulomas, 
giant cells and occasional central necrosis. Renal 
biopsy confirmed the diagnosis of sarcoidosis 
by demonstrating non-caseating granuloma. 
Symptoms resolved with high dose oral 
prednisolone.
The cause of sarcoidosis remains unknown 
and its diagnosis can be challenging. Clinical 
presentation is multisystemic and can be 
confusing. Ancillary tests are helpful but none 
of them are specific and histological proof is 
not always available. CNS involvement is rare 
and represents about 5% of cases.20 Transient 
ischemic attacks and strokes occur very rarely, 
in contrast to several pathological descriptions 
of perivascular and vascular infiltration of 
meningeal and cerebral vessels by granuloma 
often with subclinical infarctions.21
Histopathological characteristics of 
APMPPE have previously been reported in a 
patient with CNS involvement. The choroid 
showed granulomatous inflammation with 
focal disruption of the RPE but the granulomas 
were not located in or near the vessels.22 It 
was hypothesized that, APMPPE results from 
ischemia of the choriocapillaris due to the 
narrowing of upstream medium arteries by 
granular infiltration.
In our patient, APMPPE was the first 
manifestation of sarcoidosis. Investigations 
revealed subclinical lung disease. There was 
no sign of central nervous system involvement. 
Many cases with APMPPE associated with 
cerebral vasculitis have been reported but only a 
few had histological confirmation.4,23-26 Most of 
the cases were controlled with steroids and/or 
immunosuppressive therapy; neurosarcoidosis 
may occur in these cases.
The frequent occurrence of a precedent 
flu-like syndrome raises the issue of a 
triggering infectious agent and a viral illness 
has been suspected. Adenovirus type 5 has 
been identified in 2 patients with APMPPE.6,27 
Vaccination has also been reported in 
association with APMPPE.5,9 These events 
may be considered as the trigger for immune 
dysregulation leading to an inflammatory 
process.
Sarcoidosis is the major differential 
diagnosis in patients with APMPPE. A positive 
biopsy is the most appropriate way to confirm 
the diagnosis. Lyme disease and tuberculosis 
should also be ruled out. In our patient, certain 
signs including a positive tuberculin skin test 
and mediastinal lymph node calcifications 
were in favor of tuberculosis. However, the 
patient had previous BCG vaccination, the 
Quantiferon-TB Gold was negative, and 
mediastinal lesions were nonspecific. Moreover, 
high dose corticosteroids and cyclophosphamide 
did not lead to reactivation of presumed latent 
tuberculosis. Internists and neurologists played 
active roles in the management of this patient. 
In the absence of histological confirmation, 
other parameters should be considered in order 
to propose presumed, probable or possible 
sarcoidosis.28
Due to mild to moderate ocular involvement 
in our patient and the absence of significant 
complications, we did not start anti-
inflammatory treatment, initially. However, 
cardiac involvement in patients with sarcoidosis 
has been reported in 25-39% of patients and is 
responsible for up to 85% of deaths attributed 
to the disease, often due to sudden cardiac 
death. Therefore, aggressive anti-inflammatory 
therapy and immunosuppressive drugs were 
initiated in our patient. The ophthalmologist 
may be the first physician to be confronted 
with the disease and plays a major role in 
establishing the diagnosis and referring the 
patient for appropriate therapy, thus avoiding 
a fatal outcome.Sarcoidosis Manifesting as APMPPE; Darugar et al
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